Aarkstore - Paroxysmal Nocturnal Hemoglobinuria-Pipeline Insights, 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Paroxysmal Nocturnal Hemoglobinuria-Pipeline Insights, 2014

Description:

DelveInsights, Paroxysmal Nocturnal Hemoglobinuria-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Paroxysmal Nocturnal Hemoglobinuria. – PowerPoint PPT presentation

Number of Views:38

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Paroxysmal Nocturnal Hemoglobinuria-Pipeline Insights, 2014


1
Paroxysmal Nocturnal Hemoglobinuria-Pipeline
Insights, 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/healthcare/77316/-paroxys
    mal-nocturnal-hemoglobinuria-pipeline-insights-201
    4

2
Summary
  • DelveInsights, Paroxysmal Nocturnal
    Hemoglobinuria-Pipeline Insights, 2014, report
    provides comprehensive insights about pipeline
    drugs across this indication. A key objective of
    the report is to establish the understanding for
    all the pipeline drugs that fall under Paroxysmal
    Nocturnal Hemoglobinuria. This report provides
    information on the therapeutic development based
    on the Paroxysmal Nocturnal Hemoglobinuria
    dealing with all the pipeline drugs, comparative
    analysis at various stages covering Filed, Phase
    III, Phase II, Phase I, IND filed, Preclinical,
    Discovery and unknown stages, therapeutics
    assessment by monotherapy and combination
    products and molecule type drug information. The
    report also covers the companies information
    involved in the therapeutic development of the
    products. It also has highlighted the
    discontinued and dormant products.

3
Summary
  • Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts. Secondary
    sources information and data has been collected
    from various printable and non-printable sources
    like search engines, News websites, Government
    Websites, Trade Journals, White papers,
    Magazines, Trade associations, Books, Industry
    Portals, Industry Associations and access to
    available databases. Note This report requires
    certain updates. We have all the information
    available but require 3 business days to complete
    the process and ensure it is as up-to-date as
    possible. Certain sections in the report may be
    removed or altered based on the availability and
    relevance of data for the indicated Indication.

4
Summary
  • Scope 
  • The report provides a snapshot of the global
    therapeutic landscape of Paroxysmal Nocturnal
    Hemoglobinuria The report provides pipeline
    products under drug profile section which
    includes product description, MOA, licensors
    collaborators, development partner and chemical
    information Coverage of the Paroxysmal Nocturnal
    Hemoglobinuria pipeline on the basis of target,
    MOA, route of administration, technology involved
    and molecule type The report reviews key players
    involved in the therapeutics development for
    Paroxysmal Nocturnal Hemoglobinuria and also
    provide company profiling The report also gives
    the information of dormant and discontinued
    pipeline projects  Pipeline products coverage
    based on various stages of development ranging
    from preregistration till discovery and
    undisclosed stages  Provides pipeline assessment
    by monotherapy and combination therapy products,
    stage of development and molecule type

5
Summary
  • Reasons to buy Complete Pipeline intelligence
    and complete understanding over therapeutics
    development for Paroxysmal Nocturnal
    Hemoglobinuria Identify the relationship between
    the drugs and use it for target finding, drug
    repurposing, and precision medicine. Devise
    corrective measures for pipeline projects by
    understanding Paroxysmal Nocturnal Hemoglobinuria
    pipeline depth and focus of Indication
    therapeutics  Developing strategic initiatives to
    support your drug development activities. Optimize
    your portfolio and keep you in touch with the
    rapidly changing pharmaceutical markets, and make
    the best decisions for your business.

6
Summary
  • Develop and design in licensing and out licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope Provides
    strategically significant competitor information,
    analysis, and insights to formulate effective RD
    development strategies  Modify the therapeutic
    portfolio by identifying discontinued projects
    and understanding the factors that drove them
    from pipeline Gaining a Full Picture of the
    Competitive Landscape for Evidence based
    Decisions You can order full Report with TOC and
    for Sample page visit _at_ http//www.aarkstore.com/h
    ealthcare/77316/-paroxysmal-nocturnal-hemoglobinur
    ia-pipeline-insights-2014

7
Table of Content
  • Paroxysmal Nocturnal Hemoglobinuria
    Overview Paroxysmal Nocturnal Hemoglobinuria
    Pipeline Therapeutics Paroxysmal Nocturnal
    Hemoglobinuria Therapeutics under Development by
    Companies  Paroxysmal Nocturnal Hemoglobinuria
    Late Stage Products (Filed and Phase
    III) Comparative Analysis  Paroxysmal Nocturnal
    Hemoglobinuria Mid Clinical Stage Products (Phase
    II) Comparative Analysis  Paroxysmal Nocturnal
    Hemoglobinuria Early Clinical Stage Products
    (Phase I and IND Filed) Comparative
    Analysis  Paroxysmal Nocturnal Hemoglobinuria
    Discovery and Pre-Clinical Stage
    Products  Comparative Analysis  Drug Candidate
    Profiles

8
Table of Content
  • Paroxysmal Nocturnal Hemoglobinuria Therapeutics
    Assessment  Assessment by Monotherapy
    Products  Assessment by Combination
    Products  Assessment by Route of
    Administration  Assessment by Molecule
    Type  Paroxysmal Nocturnal Hemoglobinuria
    Discontinued Products  Paroxysmal Nocturnal
    Hemoglobinuria Dormant Products Companies
    Involved in Therapeutics Development for
    Paroxysmal Nocturnal Hemoglobinuria  Appendix  Met
    hodology  Contact Us  Disclaimer

9
List of Tables
  • Number of Products under Development for
    Paroxysmal Nocturnal Hemoglobinuria, 2014 Number
    of Products under Development by
    Companies  Comparative Analysis by Late Clinical
    Stage Products (Filed and Phase III),
    2014 Comparative Analysis Mid Clinical Stage
    Products (Phase II), 2014 Comparative Analysis
    Early Clinical Stage Products (Phase I and IND
    Filed), 2014 Comparative Analysis Discovery and
    Pre-Clinical Stage Products, 2014 Drug Candidates
    Profiles Paroxysmal Nocturnal Hemoglobinuria
    Assessment by Monotherapy Products  Paroxysmal
    Nocturnal Hemoglobinuria Assessment by
    Combination Products  Paroxysmal Nocturnal
    Hemoglobinuria Assessment by Route of
    Administration

10
List of Tables
  • Paroxysmal Nocturnal Hemoglobinuria Assessment by
    Stage and Route of Administration  Paroxysmal
    Nocturnal Hemoglobinuria Assessment by Molecule
    Type  Paroxysmal Nocturnal Hemoglobinuria
    Assessment by Stage and Molecule Type  Paroxysmal
    Nocturnal Hemoglobinuria Therapeutics
    Discontinued Products  Paroxysmal Nocturnal
    Hemoglobinuria Therapeutics Dormant
    Products Products under Development by Companies,
    2014

11
List of Figures
  • Number of Products under Development for
    Paroxysmal Nocturnal Hemoglobinuria, 2014 Late
    Clinical Stage Products (Filed and Phase III),
    2014 Mid Clinical Stage Products (Phase II),
    2014 Early Clinical Stage Products (Phase I and
    IND Filed), 2014 Discovery and Pre-Clinical Stage
    Products, 2014 Paroxysmal Nocturnal
    Hemoglobinuria Assessment by Monotherapy
    Products  Paroxysmal Nocturnal Hemoglobinuria
    Assessment by Combination Products  Paroxysmal
    Nocturnal Hemoglobinuria Assessment by Route of
    Administration  Paroxysmal Nocturnal
    Hemoglobinuria Assessment by Stage and Route of
    Administration  Paroxysmal Nocturnal
    Hemoglobinuria Assessment by Molecule
    Type  Paroxysmal Nocturnal Hemoglobinuria
    Assessment by Stage and Molecule Type

12
Related Reports
  • 2015 Worldwide Medical Laboratories
    Industry-Industry Market Report
  • 2015 Worldwide Pharmaceutical Preparation Mfg.
    Industry-Industry Market Report
  • OncoPlex Diagnostics - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • MetaStat, Inc. - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Advanced Cell Diagnostics, Inc. - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • Ascension Health - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Accretive Health, Inc. (ACHI) - Strategic SWOT
    Analysis Review
  • Jazz Pharmaceuticals plc (JAZZ) - Financial and
    Strategic SWOT Analysis Review
  • Pharmstandard (PHST) - Financial and Strategic
    SWOT Analysis Review
  • GLG Life Tech Corporation (GLG) - Financial and
    Strategic SWOT Analysis Review

13
  • Paroxysmal Nocturnal Hemoglobinuria-Pipeline
    Insights, 2014
  • Published Dec. 2014 60 Pages
  • DelveInsights, Paroxysmal Nocturnal
    Hemoglobinuria-Pipeline Insights, 2014, report
    provides comprehensive insights about pipeline
    drugs across this indication.
    Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor, B-Wing,
Mahaavir Icon,  Plot No.- 89 90,
Sector-15, CBD-Belapur, Navi Mumbai
400614,  Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com